patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Pluristem Announces Proposed Public Offering of Common Stock and Warrants to Pur

Figured it was coming - all depends on who gets them I guess.

Wish edig would rally little,,, I'd catch this dip.

e

Share
New Message
Please login to post a reply